Diagnostic Performance of Positron Emission Mammography in Breast Cancer

Investigate the accuracy of PEM in detection of breast cancer.

Not Yet Recruiting

Trial opening soon.

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–80 year

Sex eligibility

Female

Study type

Observational

About this study

Investigate the accuracy of positron emission mammography as non invasive method for early detection of breast cancer especially small sized cancers.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients suspected with breast cancer.

Exclusion criteria

patient with glucose level >200 mg/dl.
Pregnant patients

Treatment and study plan

PEM

Device

Accuracy of PEM in detection of breast cancer

Primary outcomes

Diagnostic performance of positron emission mammography in breast cancer

Time frame: Base line

Investigate PEM as non invasive method for early detection of breast cancer

Study contacts

Contact information is provided by the study sponsor or research team.

Maha Khalil Mahmoud

CONTACT

[email protected]

+20 10 04037100

Zainab Fathy Mohammad

CONTACT

[email protected]

+20 01099024404

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Jan 24, 2025
Registry last updated: Jan 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting